NanoString Technologies Inc. (US) and Bio-Rad Laboratories, Inc. (US) are Leading Players in the Spatial Genomics & Transcriptomics Market

The global spatial genomics and transcriptomics market is expected to reach USD 995.7 million in 2029 from USD 554.5 million in 2024, at a CAGR of 12.4% during the forecast period. The main factors behind the expansion of this market are increasing development in the area such as neurodegenerative diseases and cancer. Along with this, launch of several advanced products are contributing towards the growth of the market. On the other hand, need of high initial investments, and dearth of skilled professionals are some factors limiting the market growth.

The spatial genomics and transcriptomics market is consolidated with key players such NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Seven Bridges Genomics (US), Standard BioTools (US), Revvity (US), Akoya Biosciences, Inc. (US), Natera, Inc. (US), VisioPharm A/S (Switzerland), Danaher Corporation (US), Veracyte, Inc. (US), Macrogen, Inc. (South Korea), Miltenyi Biotec (Germany), Vizgen Inc. (US). The market players have adopted various strategies such as development of advanced products, services, partnerships, contracts, expansions, and acquisitions to strengthen their position in the spatial genomics and transcriptomics market. The organic and inorganic strategies have helped the market players expand globally by providing advanced spatial genomics and transcriptomics products and services.

To know about the assumptions considered for the study download the pdf brochure

NanoString Technologies Inc. (US)

NanoString Technologies, Inc. is a public company that makes tools for translatable study and molecular diagnostics in the life sciences. NanoString has made a number of tools that allow scientists to look at gene and protein activity in a single piece of tissue. The company is steadily growing and being seen in the market. NanoString has the most revenue of the companies on the list. Its GeoMx Digital Spatial Profiler is a big part of how well it does in spatial transcriptomics, especially in oncology and immunology studies.

Bio-Rad Laboratories, Inc. (US)

Bio-Rad Laboratories, Inc. is a world leader in creating, producing, and selling a wide range of study and diagnostic tools for life sciences. Bio-Rad provides a wide range of instruments, software, services, and materials for life science study, such as genomics and transcriptomics, but its revenue share is lower than that of some other companies. The company's slow growth suggests that it is focussing on a specific niche. Its products help researchers study gene expression and cellular interactions within tissues, which gives them important information about how diseases work and possible therapeutic targets. These products are not directly competing with other spatial platform technologies.

Bio-Techne (US)

Bio-Techne is well-known for its RNAscope technology in the framework of spatial genomics and transcriptomics since it enables single-molecule sensitivity and subcellular resolution of RNA expression. From neuroscience to cancer research to infectious diseases, this technique is extensively applied in many disciplines to offer thorough understanding of gene expression and cellular interactions inside tissues. Steady revenue growth of Bio-Techne suggests continuous demand for its reagents throughout spatial applications, including genomics, so enabling its increasing position in the market.

10x Genomics (US)

10x Genomics is a major life sciences company offering revolutionary technologies for single-cell and spatial biology research. The company provides technologies that help researchers investigate biological systems with unparalleled resolution. lox Genomics offers Visium Spatial Gene Expression and Xenium In Situ platforms for spatial and transcriptomics research. These tools enable scientists to map gene expression in tissue sections, revealing cellular composition, relationships, and spatial organisation. lox Genomics' technologies combine histology and gene expression data, enabling researchers to gain new insights into health and illness.

Illumina, Inc. (US)

Illumina is a global pioneer in genomics and molecular diagnostics, offering advanced sequencing and array technologies for many applications. Illumina provides comprehensive solutions for the research, clinical, and application markets. Illumina offers sequencing platforms and software analysis tools for spatial genomics and transcriptomics, integrating with partner solutions to deliver a comprehensive solution. Their technology allows researchers to map gene expression in tissue sections, revealing cellular composition, relationships, and spatial organisation. Illumina's tools combine histology and gene expression data, enabling researchers to gain new insights into health and disease.

Related Reports:

Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]